A regulatory BCL2 promoter polymorphism (-938C>A) is associated with outcome in neuroblastoma

Authors :: Angelika Eggert
Kristian W. Pajtler
Johannes H. Schulte
Bent Brockmeyer
W Siffert
Alexander Schramm
A Künkele
Hagen S. Bachmann
Source :: Klinische Pädiatrie. 222
Publication Year :: 2010
Publisher :: Georg Thieme Verlag KG, 2010.

Subjects :: business.industry
Neuroblastoma
Pediatrics, Perinatology and Child Health
Cancer research
Promoter polymorphism
Medicine
business
medicine.disease
Outcome (game theory)

Tools